2-MeCCPA is a potent and selective A1 adenosine receptors (A1AR) agonist. 2-MeCCPA efficiently inhibits cAMP modulation in both direct pathway medium spiny neurons (dMSNs) and indirect pathway medium spiny neurons (iMSNs).
性状
Solid
IC50 & Target[1][2]
A1AR
体内研究(In Vivo)
2’-MeCCPA (1?nM-1 M) at reperfusion significantly reduces infarct size to risk ratio in male Sprague-Dawley rats.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.